All Stories

  1. Clinical characteristics and management of patients with secondary hyperparathyroidism undergoing hemodialysis: a feasibility analysis of electronic health records using Natural Language Processing

    Article • Kidney Diseases, January 2023, Karger Publishers

    prof alberto ortiz

  2. Bone Marrow–Derived RIPK3 Mediates Kidney Inflammation in Acute Kidney Injury

    Article • Journal of the American Society of Nephrology, January 2022, American Society of Nephrology

    prof alberto ortiz

  3. Curcumin reduces acute kidney injury and ferroptosis

    Article • The FASEB Journal, April 2019, Federation of American Societies For Experimental Biology (FASEB)

    Javier Egea, prof alberto ortiz , Alfonso Rubio Navarro, Juan Antonio Moreno , Melania Guerrero Hue

  4. Advances in understanding the role of angiotensin-regulated proteins in kidney diseases

    Article • Expert Review of Proteomics, November 2018, Taylor & Francis

    prof alberto ortiz , Marta Ruiz Ortega

  5. The effect of enzyme replacement therapy on clinical outcomes in female patients with Fabry disease – A systematic literature review by a European panel of experts

    Article • Molecular Genetics and Metabolism, September 2018, Elsevier

    prof alberto ortiz

  6. Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression

    Article • Toxins, July 2018, MDPI AG

    prof alberto ortiz

  7. Correction: Mas, S., et al. Identification and Chemical Characterization of Insoluble Contaminants in Hemodialysis Water Treatment. Water 2018, 10, 486

    Article • Water, June 2018, MDPI AG

    prof alberto ortiz

  8. Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD)

    Article • Toxins, June 2018, MDPI AG

    prof alberto ortiz

  9. Identification and Chemical Characterization of Insoluble Contaminants in Hemodialysis Water Treatment

    Article • Water, April 2018, MDPI AG

    prof alberto ortiz

  10. Fabry disease revisited: Management and treatment recommendations for adult patients

    Article • Molecular Genetics and Metabolism, April 2018, Elsevier

    prof alberto ortiz

  11. Cell death-based approaches in treatment of the urinary tract-associated diseases: a fight for survival in the killing fields

    Article • Cell Death and Disease, January 2018, Nature

    prof alberto ortiz

  12. Lipid Management in Chronic Kidney Disease: Systematic Review of PCSK9 Targeting

    Article • Drugs, January 2018, Springer Science + Business Media

    prof alberto ortiz

  13. Nutrients Turned into Toxins: Microbiota Modulation of Nutrient Properties in Chronic Kidney Disease

    Article • Nutrients, May 2017, MDPI AG

    prof alberto ortiz

  14. Expression of uPAR in Urinary Podocytes of Patients with Fabry Disease

    Article • International Journal of Nephrology, January 2017, Hindawi Publishing Corporation

    Dr hernan trimarchi, Dr Elsa Zotta, prof alberto ortiz

  15. Creatinine Clearance Is Not Equal to Glomerular Filtration Rate and Cockcroft-Gault Equation Is Not Equal to CKD-EPI Collaboration Equation

    Article • The American Journal of Medicine, December 2016, Elsevier

    prof alberto ortiz

  16. Enzyme Replacement Therapy for Fabry Disease

    Article • Journal of Inborn Errors of Metabolism and Screening, November 2016, SAGE Publications

    prof alberto ortiz

  17. Downregulation of kidney protective factors by inflammation: role of transcription factors and epigenetic mechanisms

    Article • AJP Renal Physiology, October 2016, American Physiological Society

    prof alberto ortiz

  18. Atrial fibrillation in chronic kidney disease

    Article • European Journal of Internal Medicine, September 2016, Elsevier

    prof alberto ortiz

  19. Calcineurin inhibitors cyclosporine A and tacrolimus induce vascular inflammation and endothelial activation through TLR4 signaling

    Article • Scientific Reports, June 2016, Nature

    prof alberto ortiz

  20. Hypertension in Chronic Kidney Disease Part 1

    Article • Hypertension, May 2016, Wolters Kluwer Health

    prof alberto ortiz

  21. Hypertension in Chronic Kidney Disease Part 2

    Article • Hypertension, May 2016, Wolters Kluwer Health

    prof alberto ortiz

  22. Out of the TWEAKlight: Elucidating the Role of Fn14 and TWEAK in Acute Kidney Injury

    Article • Seminars in Nephrology, May 2016, Elsevier

    prof alberto ortiz

  23. Histone lysine crotonylation during acute kidney injury in mice

    Article • Disease Models & Mechanisms, April 2016, The Company of Biologists

    prof alberto ortiz

  24. Atherosclerotic renal artery stenosis in the post-CORAL era part 1: the renal penumbra concept and next-generation functional diagnostic imaging

    Article • Journal of the American Society of Hypertension, April 2016, Elsevier

    prof alberto ortiz

  25. Atherosclerotic renal artery stenosis in the post-CORAL era part 2: new directions in Transcatheter Nephron Salvage following flawed revascularization trials

    Article • Journal of the American Society of Hypertension, April 2016, Elsevier

    prof alberto ortiz

  26. Clinical management of the uraemic syndrome in chronic kidney disease

    Article • The Lancet Diabetes & Endocrinology, April 2016, Elsevier

    prof alberto ortiz

  27. Corrigendum to “IRS2 and PTEN are key molecules in controlling insulin sensitivity in podocytes” [Biochim. Biophys. Acta 1853 (12) (2015) 3224–3234]

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, April 2016, Elsevier

    prof alberto ortiz

  28. NFκBiz protein downregulation in acute kidney injury: Modulation of inflammation and survival in tubular cells

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, April 2016, Elsevier

    prof alberto ortiz

  29. Osteoprotegerin in Chronic Kidney Disease: Associations with Vascular Damage and Cardiovascular Events

    Article • Calcified Tissue International, March 2016, Springer Science + Business Media

    prof alberto ortiz

  30. Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients

    Article • International Urology and Nephrology, March 2016, Springer Science + Business Media

    prof alberto ortiz

  31. Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial

    Article • BMJ Open, March 2016, BMJ

    Dr Frederik Persson, prof alberto ortiz

  32. Cómo debemos analizar y describir la mortalidad de nuestros pacientes: experiencia del Grupo Centro Diálisis Peritoneal

    Article • Nefrología, March 2016, Elsevier

    prof alberto ortiz

  33. The inflammatory cytokine TWEAK decreases PGC-1α expression and mitochondrial function in acute kidney injury

    Article • Kidney International, February 2016, Elsevier

    prof alberto ortiz

  34. Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice

    Article • Nephrology Dialysis Transplantation, January 2016, Oxford University Press (OUP)

    prof alberto ortiz , Professor Albert Ong

  35. Urinary Kininogen-1 and Retinol binding protein-4 respond to Acute Kidney Injury: predictors of patient prognosis?

    Article • Scientific Reports, January 2016, Nature

    prof alberto ortiz

  36. Small vessel microembolization and acute glomerulonephritis following infection of aesthetic filler implants

    Article • Diagnostic Pathology, January 2016, Springer Science + Business Media

    prof alberto ortiz

  37. IRS2 and PTEN are key molecules in controlling insulin sensitivity in podocytes

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, December 2015, Elsevier

    prof alberto ortiz

  38. The fate of triaged and rejected manuscripts

    Article • Nephrology Dialysis Transplantation, November 2015, Oxford University Press (OUP)

    prof alberto ortiz

  39. Thrombotic microangiopathy: expanding genetic, clinical and therapeutic spectra and the need for worldwide implementation of recent advances

    Article • Clinical Kidney Journal, November 2015, Oxford University Press (OUP)

    prof alberto ortiz

  40. Evaluation of the efficacy and safety of three dosing regimens of agalsidase alfa enzyme replacement therapy was underpowered

    Article • Drug Design Development and Therapy, November 2015, Dove Medical Press

    prof alberto ortiz

  41. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition

    Article • The Lancet, November 2015, Elsevier

    Professor David M. Pereira, Dr Lorenzo Monasta, Dr Francis A Mhimbira, Dr marek majdan, prof alberto ortiz , Kathryn H. Jacobsen, Maysaa El Sayed Zaki, Professor Amanda G Thrift, Dr Azmeraw Amare, Ione Schneider, Mr Raimundas Lunevicius, Professor Yousef Khader, Dr. Jasvinder A. Singh, Tommi Vasankari, Dr. Bolajoko O. Olusanya

  42. Kidney tissue proteomics reveals regucalcin downregulation in response to diabetic nephropathy with reflection in urinary exosomes

    Article • Translational Research, November 2015, Elsevier

    prof alberto ortiz

  43. The double challenge of resistant hypertension and chronic kidney disease

    Article • The Lancet, October 2015, Elsevier

    prof alberto ortiz

  44. CD74 in Kidney Disease

    Article • Frontiers in Immunology, September 2015, Frontiers

    prof alberto ortiz

  45. Targeting local vascular and systemic consequences of inflammation on vascular and cardiac valve calcification

    Article • Expert Opinion on Therapeutic Targets, September 2015, Informa Healthcare

    prof alberto ortiz

  46. Haemodialysate: long neglected, difficult to optimize, may modify hard outcomes

    Article • Clinical Kidney Journal, September 2015, Oxford University Press (OUP)

    prof alberto ortiz

  47. Important abnormalities of bone mineral metabolism are present in patients with coronary artery disease with a mild decrease of the estimated glomerular filtration rate

    Article • Journal of Bone and Mineral Metabolism, August 2015, Springer Science + Business Media

    prof alberto ortiz

  48. Phosphodiesterase type 5 inhibitors and kidney disease

    Article • International Urology and Nephrology, August 2015, Springer Science + Business Media

    Dr Abduzhappar Gaipov, prof alberto ortiz

  49. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

    Article • The Lancet, August 2015, Elsevier

    Professor David M. Pereira, Dr Farshad Pourmalek, Dr Francis A Mhimbira, Dr marek majdan, Nadine Steckling, prof alberto ortiz , Kathryn H. Jacobsen, Maysaa El Sayed Zaki, Professor Amanda G Thrift, Mr Raimundas Lunevicius, Professor Yousef Khader, Dr. Jasvinder A. Singh, Tommi Vasankari, Professor Alina Rodriguez

  50. Timing of eculizumab therapy for C3 glomerulonephritis

    Article • Clinical Kidney Journal, July 2015, Oxford University Press (OUP)

    prof alberto ortiz

  51. Lyso-Gb3 activates Notch1 in human podocytes

    Article • Human Molecular Genetics, July 2015, Oxford University Press (OUP)

    prof alberto ortiz

  52. Decreasing incidence of renal replacement therapy over time at the critical 50–59-year age range suggests a role for nephroprotective therapy in ADPKD

    Article • Kidney International, July 2015, Elsevier

    prof alberto ortiz

  53. Humble kidneys predict mighty heart troubles

    Article • The Lancet Diabetes & Endocrinology, July 2015, Elsevier

    prof alberto ortiz

  54. Translational value of animal models of kidney failure

    Article • European Journal of Pharmacology, July 2015, Elsevier

    prof alberto ortiz

  55. Combination use of medicines from two classes of renin-angiotensin system blocking agents: risk of hyperkalemia, hypotension, and impaired renal function

    Article • Therapeutic Advances in Drug Safety, June 2015, SAGE Publications

    prof alberto ortiz

  56. 2012 ERA-EDTA Registry Annual Report: cautious optimism on outcomes, concern about persistent inequalities and data black-outs

    Article • Clinical Kidney Journal, May 2015, Oxford University Press (OUP)

    prof alberto ortiz

  57. Validity of Vascular Calcification as a Screening Tool and as a Surrogate End Point in Clinical Research

    Article • Hypertension, May 2015, Wolters Kluwer Health

    prof alberto ortiz

  58. Modifiable Risk Factors for Increased Arterial Stiffness in Outpatient Nephrology

    Article • PLoS ONE, April 2015, PLOS

    prof alberto ortiz

  59. Designing drugs that combat kidney damage

    Article • Expert Opinion on Drug Discovery, April 2015, Informa Healthcare

    prof alberto ortiz

  60. TNF-related weak inducer of apoptosis (TWEAK) regulates junctional proteins in tubular epithelial cells via canonical NF-κB pathway and ERK activation

    Article • Journal of Cellular Physiology, March 2015, Wiley

    prof alberto ortiz

  61. Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease

    Article • Nephrology Dialysis Transplantation, March 2015, Oxford University Press (OUP)

    prof alberto ortiz , Dr Jose M Valdivielso, MD, PhD Aleix Cases

  62. Biocompatibility Reduces Inflammation-Induced Apoptosis in Mesothelial Cells Exposed to Peritoneal Dialysis Fluid

    Article • Blood Purification, March 2015, Karger Publishers

    prof alberto ortiz

  63. Angiotensin II, via angiotensin receptor type 1/nuclear factor-κB activation, causes a synergistic effect on interleukin-1-β-induced inflammatory responses in cultured mesangial cells

    Article • Journal of the Renin-Angiotensin-Aldosterone System, March 2015, SAGE Publications

    prof alberto ortiz , Marta Ruiz Ortega

  64. Association between the IL17RA rs4819554 polymorphism and reduced renal filtration rate in the Spanish RENASTUR cohort

    Article • Human Immunology, March 2015, Elsevier

    prof alberto ortiz

  65. Albumin-induced apoptosis of tubular cells is modulated by BASP1

    Article • Cell Death and Disease, February 2015, Nature

    prof alberto ortiz

  66. The alpha-galactosidase A p.Arg118Cys variant does not cause a Fabry disease phenotype: Data from individual patients and family studies

    Article • Molecular Genetics and Metabolism, February 2015, Elsevier

    prof alberto ortiz

  67. Chronic kidney disease and an uncertain diagnosis of Fabry disease: Approach to a correct diagnosis

    Article • Molecular Genetics and Metabolism, February 2015, Elsevier

    prof alberto ortiz

  68. Healthcare-associated infections: new challenges looking for answers

    Article • Clinical Kidney Journal, January 2015, Oxford University Press (OUP)

    prof alberto ortiz

  69. Translational nephrology: what translational research is and a bird's-eye view on translational research in nephrology

    Article • Clinical Kidney Journal, January 2015, Oxford University Press (OUP)

    prof alberto ortiz

  70. Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides

    Article • Journal of the American Society of Nephrology, January 2015, American Society of Nephrology

    Dr Frederik Persson, prof alberto ortiz

  71. Welcome to the new ckj: an open-access resource integrating clinical, translational and educational research into clinical practice

    Article • Clinical Kidney Journal, January 2015, Oxford University Press (OUP)

    prof alberto ortiz

  72. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

    Article • The Lancet, January 2015, Elsevier

    Mr Heresh Amini, Professor David M. Pereira, Dr Francis A Mhimbira, Dr Farshad Pourmalek, Dr marek majdan, prof alberto ortiz , Dr Arindam Basu, Kathryn H. Jacobsen, Maysaa El Sayed Zaki, Professor Amanda G Thrift, Hiroshi Yatsuya, Dr Azmeraw Amare, Mr Raimundas Lunevicius, Professor Yousef Khader, Dr. Jasvinder A. Singh, Tommi Vasankari, Professor Alina Rodriguez, Dr. Bolajoko O. Olusanya, Professor ORISH EBERE ORSAKWE

  73. Paricalcitol Inhibits Aldosterone-Induced Proinflammatory Factors by Modulating Epidermal Growth Factor Receptor Pathway in Cultured Tubular Epithelial Cells

    Article • BioMed Research International, January 2015, Hindawi Publishing Corporation

    prof alberto ortiz

  74. TGF-Beta Blockade Increases Renal Inflammation Caused by the C-Terminal Module of the CCN2

    Article • Mediators of Inflammation, January 2015, Hindawi Publishing Corporation

    prof alberto ortiz

  75. The C-Terminal Module IV of Connective Tissue Growth Factor, Through EGFR/Nox1 Signaling, Activates the NF-κB Pathway and Proinflammatory Factors in Vascular Smooth Muscle Cells

    Article • Antioxidants & Redox Signaling, January 2015, Mary Ann Liebert Inc

    prof alberto ortiz

  76. CKD hotspots around the world: where, why and what the lessons are. A CKJ review series

    Article • Clinical Kidney Journal, November 2014, Oxford University Press (OUP)

    prof alberto ortiz

  77. Bicarbonate therapy, phosphate binders, and risk for vascular calcification

    Article • Kidney International, November 2014, Elsevier

    prof alberto ortiz

  78. Erratum

    Article • Nephrology Dialysis Transplantation, October 2014, Oxford University Press (OUP)

    prof alberto ortiz , Prof. Carmine Zoccali

  79. Peritoneal Dialysis Can Be an Option for Dominant Polycystic Kidney Disease: an Observational Study

    Article • Peritoneal Dialysis International, October 2014, MultiMed Inc.

    prof alberto ortiz

  80. Cortisol levels are associated with mortality risk in hemodialysis patients

    Article • Clinical Nephrology, October 2014, Dustri-Verlgag Dr. Karl Feistle

    prof alberto ortiz

  81. Klotho Prevents NFκB Translocation and Protects Endothelial Cell From Senescence Induced by Uremia

    Article • The Journals of Gerontology Series A, September 2014, Oxford University Press (OUP)

    prof alberto ortiz , Julia Carracedo

  82. Urine 2DE proteome analysis in healthy condition and kidney disease

    Article • Electrophoresis, August 2014, Wiley

    prof alberto ortiz

  83. Galectin-3, a Biomarker Linking Oxidative Stress and Inflammation With the Clinical Outcomes of Patients With Atherothrombosis

    Article • Journal of the American Heart Association, August 2014, Wolters Kluwer Health

    prof alberto ortiz

  84. IL-17A is a novel player in dialysis-induced peritoneal damage

    Article • Kidney International, August 2014, Elsevier

    prof alberto ortiz

  85. Deferasirox nephrotoxicity—the knowns and unknowns

    Article • Nature Reviews Nephrology, July 2014, Nature

    prof alberto ortiz

  86. Application of the New Cholesterol Guidelines

    Article • New England Journal of Medicine, July 2014, New England Journal of Medicine (NEJM/MMS)

    prof alberto ortiz

  87. Integrin-linked kinase plays a key role in the regulation of angiotensin II-induced renal inflammation

    Article • Clinical Science, July 2014, Portland Press Ltd.

    prof alberto ortiz

  88. 'That Obscure Object of Desire': in systemic lupus erythematosus B-cell activating factor/B-lymphocyte stimulator is targeted both by the immune system and by physicians

    Article • Nephrology Dialysis Transplantation, June 2014, Oxford University Press (OUP)

    prof alberto ortiz

  89. CXCL16 in kidney and cardiovascular injury

    Article • Cytokine & Growth Factor Reviews, June 2014, Elsevier

    prof alberto ortiz

  90. Relevant role of PKG in the progression of fibrosis induced by TNF-like weak inducer of apoptosis

    Article • AJP Renal Physiology, May 2014, American Physiological Society

    prof alberto ortiz

  91. Next-Generation Phosphate Binders: Focus on Iron-Based Binders

    Article • Drugs, May 2014, Springer Science + Business Media

    prof alberto ortiz

  92. Therapeutic approaches to diabetic nephropathy—beyond the RAS

    Article • Nature Reviews Nephrology, May 2014, Nature

    prof alberto ortiz

  93. Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure

    Article • The Lancet, May 2014, Elsevier

    prof alberto ortiz , Prof. Carmine Zoccali

  94. The Authors Reply:

    Article • Kidney International, May 2014, Elsevier

    prof alberto ortiz

  95. Osteoprotegerin and kidney disease

    Article • Journal of Nephrology, April 2014, Springer Science + Business Media

    prof alberto ortiz

  96. TWEAK Promotes Peritoneal Inflammation

    Article • PLoS ONE, March 2014, PLOS

    prof alberto ortiz

  97. Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy

    Article • Nephrology Dialysis Transplantation, March 2014, Oxford University Press (OUP)

    Dr Frederik Persson, prof alberto ortiz

  98. Molecular mediators of favism-induced acute kidney injury

    Article • Clinical Nephrology, March 2014, Dustri-Verlgag Dr. Karl Feistle

    prof alberto ortiz

  99. Endogenous NAMPT dampens chemokine expression and apoptotic responses in stressed tubular cells

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, February 2014, Elsevier

    prof alberto ortiz

  100. TWEAK and the progression of renal disease: clinical translation

    Article • Nephrology Dialysis Transplantation, February 2014, Oxford University Press (OUP)

    prof alberto ortiz

  101. Role of chemokines in proteinuric kidney disorders

    Article • Expert Reviews in Molecular Medicine, January 2014, Cambridge University Press

    prof alberto ortiz

  102. Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis

    Article • Journal of Proteomics, January 2014, Elsevier

    prof alberto ortiz

  103. Gremlin Activates the Smad Pathway Linked to Epithelial Mesenchymal Transdifferentiation in Cultured Tubular Epithelial Cells

    Article • BioMed Research International, January 2014, Hindawi Publishing Corporation

    prof alberto ortiz

  104. Identification of a urine metabolomic signature in patients with advanced-stage chronic kidney disease

    Article • Kidney International, January 2014, Elsevier

    prof alberto ortiz

  105. Increasing serum calcium levels and recent return from transplantation as clues to the tuberculous nature of refractory peritoneal dialysis peritonitis

    Article • Journal of Postgraduate Medicine, January 2014, Medknow

    prof alberto ortiz

  106. Individualization of Dialysate Calcium Concentration According to Baseline Pre-Dialysis Serum Calcium

    Article • Blood Purification, January 2014, Karger Publishers

    prof alberto ortiz

  107. Mitochondria-targeted therapies for acute kidney injury

    Article • Expert Reviews in Molecular Medicine, January 2014, Cambridge University Press

    prof alberto ortiz

  108. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and kidney disease

    Article • Current Opinion in Nephrology & Hypertension, January 2014, Wolters Kluwer Health

    prof alberto ortiz

  109. Hyperlipidemia-Associated Renal Damage Decreases Klotho Expression in Kidneys from ApoE Knockout Mice

    Article • PLoS ONE, December 2013, PLOS

    prof alberto ortiz

  110. 3,4-DGE is cytotoxic and decreases HSP27/HSPB1 in podocytes

    Article • Archives of Toxicology, December 2013, Springer Science + Business Media

    prof alberto ortiz

  111. Fn14 in podocytes and proteinuric kidney disease

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, December 2013, Elsevier

    prof alberto ortiz

  112. TWEAK transactivation of the epidermal growth factor receptor mediates renal inflammation

    Article • The Journal of Pathology, November 2013, Wiley

    prof alberto ortiz

  113. Calcineurin inhibitors recruit protein kinases JAK2 and JNK, TLR signaling and the UPR to activate NF-κB-mediated inflammatory responses in kidney tubular cells

    Article • Toxicology and Applied Pharmacology, November 2013, Elsevier

    prof alberto ortiz

  114. Subclinical versus overt obesity in dialysis patients: more than meets the eye

    Article • Nephrology Dialysis Transplantation, October 2013, Oxford University Press (OUP)

    prof alberto ortiz

  115. p-Cresyl sulphate has pro-inflammatory and cytotoxic actions on human proximal tubular epithelial cells

    Article • Nephrology Dialysis Transplantation, October 2013, Oxford University Press (OUP)

    prof alberto ortiz

  116. TNF-related weak inducer of apoptosis (TWEAK) promotes kidney fibrosis and Ras-dependent proliferation of cultured renal fibroblast

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, October 2013, Elsevier

    Professor Jose M Lopez-Novoa, prof alberto ortiz

  117. The demise of calcium-based phosphate binders

    Article • The Lancet, October 2013, Elsevier

    prof alberto ortiz

  118. Assessment of arterial stiffness for clinical and epidemiological studies: methodological considerations for validation and entry into the European Renal and Cardiovascular Medicine registry

    Article • Nephrology Dialysis Transplantation, September 2013, Oxford University Press (OUP)

    prof alberto ortiz , Prof. Carmine Zoccali

  119. Unilateral ureteral obstruction: beyond obstruction

    Article • International Urology and Nephrology, September 2013, Springer Science + Business Media

    prof alberto ortiz

  120. Vascular calcification in chronic kidney disease: are biomarkers useful for probing the pathobiology and the health risks of this process in the clinical scenario?

    Article • Nephrology Dialysis Transplantation, September 2013, Oxford University Press (OUP)

    prof alberto ortiz , Prof. Carmine Zoccali

  121. A CLCNKA polymorphism (rs10927887; p.Arg83Gly) previously linked to heart failure is associated with the estimated glomerular filtration rate in the RENASTUR cohort

    Article • Gene, September 2013, Elsevier

    prof alberto ortiz

  122. Rituximab-associated interstitial lung disease in fibrillary glomerulonephritis

    Article • Clinical Kidney Journal, September 2013, Oxford University Press (OUP)

    prof alberto ortiz

  123. HCV Infection and Miravirsen

    Article • New England Journal of Medicine, August 2013, New England Journal of Medicine (NEJM/MMS)

    prof alberto ortiz

  124. Osteoprotegerin in Exosome-Like Vesicles from Human Cultured Tubular Cells and Urine

    Article • PLoS ONE, August 2013, PLOS

    prof alberto ortiz

  125. Connective tissue growth factor is a new ligand of epidermal growth factor receptor

    Article • Journal of Molecular Cell Biology, August 2013, Oxford University Press (OUP)

    prof alberto ortiz

  126. Identification of a Potent Endothelium-Derived Angiogenic Factor

    Article • PLoS ONE, July 2013, PLOS

    prof alberto ortiz

  127. Two independent pathways of regulated necrosis mediate ischemia–reperfusion injury

    Article • Proceedings of the National Academy of Sciences, July 2013, Proceedings of the National Academy of Sciences

    prof alberto ortiz

  128. Macrophages and Recently Identified Forms of Cell Death

    Article • International Reviews of Immunology, June 2013, Informa Healthcare

    prof alberto ortiz

  129. Correction of hypocalcemia allows optimal recruitment of FGF-23-dependent phosphaturic mechanisms in acute hyperphosphatemia post-phosphate enema

    Article • Journal of Bone and Mineral Metabolism, May 2013, Springer Science + Business Media

    prof alberto ortiz

  130. The C-terminal module IV of connective tissue growth factor is a novel immune modulator of the Th17 response

    Article • Laboratory Investigation, May 2013, Nature

    prof alberto ortiz

  131. Parathyroid hormone–related protein protects renal tubuloepithelial cells from apoptosis by activating transcription factor Runx2

    Article • Kidney International, May 2013, Elsevier

    prof alberto ortiz

  132. Progress in the development of animal models of acute kidney injury and its impact on drug discovery

    Article • Expert Opinion on Drug Discovery, April 2013, Informa Healthcare

    prof alberto ortiz

  133. Klotho to Treat Kidney Fibrosis

    Article • Journal of the American Society of Nephrology, April 2013, American Society of Nephrology

    prof alberto ortiz

  134. Pulmonary Hypertension in CKD

    Article • American Journal of Kidney Diseases, April 2013, Elsevier

    prof alberto ortiz , Prof. Carmine Zoccali

  135. Laser Therapy in Metabolic Syndrome‐Related Kidney Injury

    Article • Photochemistry and Photobiology, March 2013, Wiley

    prof alberto ortiz

  136. MIF, CD74 and other partners in kidney disease: Tales of a promiscuous couple

    Article • Cytokine & Growth Factor Reviews, February 2013, Elsevier

    prof alberto ortiz

  137. A Polymeric Nanomedicine Diminishes Inflammatory Events in Renal Tubular Cells

    Article • PLoS ONE, January 2013, PLOS

    prof alberto ortiz

  138. A combinatorial approach of Proteomics and Systems Biology in unravelling the mechanisms of acute kidney injury (AKI): involvement of NMDA receptor GRIN1 in murine AKI

    Article • BMC Systems Biology, January 2013, Springer Science + Business Media

    prof alberto ortiz

  139. DNA demethylation and histone H3K9 acetylation determine the active transcription of the NKG2D gene in human CD8+T and NK cells

    Article • Epigenetics, January 2013, Taylor & Francis

    prof alberto ortiz

  140. Fibrosis: a key feature of Fabry disease with potential therapeutic implications

    Article • Orphanet Journal of Rare Diseases, January 2013, Springer Science + Business Media

    prof alberto ortiz

  141. TWEAK/Fn14 and Non-Canonical NF-kappaB Signaling in Kidney Disease

    Article • Frontiers in Immunology, January 2013, Frontiers

    prof alberto ortiz

  142. Fabry nephropathy: indications for screening and guidance for diagnosis and treatment by the European Renal Best Practice

    Article • Nephrology Dialysis Transplantation, December 2012, Oxford University Press (OUP)

    prof alberto ortiz

  143. Klotho, phosphate and inflammation/ageing in chronic kidney disease

    Article • Nephrology Dialysis Transplantation, December 2012, Oxford University Press (OUP)

    prof alberto ortiz

  144. Vitamin D receptor activation and cardiovascular disease

    Article • Nephrology Dialysis Transplantation, December 2012, Oxford University Press (OUP)

    prof alberto ortiz

  145. A role for the membrane proteome in human chronic kidney disease erythrocytes

    Article • Translational Research, November 2012, Elsevier

    prof alberto ortiz

  146. Klotho modulates the stress response in human senescent endothelial cells

    Article • Mechanisms of Ageing and Development, November 2012, Elsevier

    prof alberto ortiz , Julia Carracedo

  147. Uromodulin, Inflammasomes, and Pyroptosis

    Article • Journal of the American Society of Nephrology, October 2012, American Society of Nephrology

    prof alberto ortiz

  148. Inflammatory Cytokines and Survival Factors from Serum Modulate Tweak-Induced Apoptosis in PC-3 Prostate Cancer Cells

    Article • PLoS ONE, October 2012, PLOS

    prof alberto ortiz

  149. Notch3 and kidney injury: never two without three

    Article • The Journal of Pathology, October 2012, Wiley

    prof alberto ortiz

  150. The use of echocardiography in observational clinical trials: the EURECA-m registry

    Article • Nephrology Dialysis Transplantation, October 2012, Oxford University Press (OUP)

    prof alberto ortiz , Prof. Carmine Zoccali

  151. Fabry disease: the many faces of a single disorder

    Article • Clinical Kidney Journal, October 2012, Oxford University Press (OUP)

    prof alberto ortiz

  152. Is it or is it not a pathogenic mutation? Is it or is it not the podocyte?

    Article • Journal of Nephropathology, October 2012, International Society for Phytocosmetic Scicences

    prof alberto ortiz

  153. Cardiovascular risk biomarkers in CKD: the inflammation link and the road less traveled

    Article • International Urology and Nephrology, September 2012, Springer Science + Business Media

    prof alberto ortiz

  154. Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats

    Article • Kidney International, September 2012, Elsevier

    prof alberto ortiz

  155. Phosphate: a stealthier killer than previously thought?

    Article • Cardiovascular Pathology, September 2012, Elsevier

    prof alberto ortiz

  156. Targeting chemokines in proteinuria-induced renal disease

    Article • Expert Opinion on Therapeutic Targets, July 2012, Informa Healthcare

    prof alberto ortiz

  157. Angiotensin II Contributes to Renal Fibrosis Independently of Notch Pathway Activation

    Article • PLoS ONE, July 2012, PLOS

    prof alberto ortiz

  158. AG490 Promotes HIF-1α Accumulation by Inhibiting Its Hydroxylation

    Article • Current Medicinal Chemistry, July 2012, Bentham Science Publishers

    prof alberto ortiz

  159. TWEAK (tumor necrosis factor–like weak inducer of apoptosis) activates CXCL16 expression during renal tubulointerstitial inflammation

    Article • Kidney International, June 2012, Elsevier

    prof alberto ortiz

  160. High prevalence of winter 25-hydroxyvitamin D deficiency despite supplementation according to guidelines for hemodialysis patients

    Article • Clinical and Experimental Nephrology, May 2012, Springer Science + Business Media

    prof alberto ortiz

  161. Juxtaglomerular apparatus hyperplasia under dual angiotensin blockade. A footprint of adequate RAS inhibition or a concern for renal fibrosis?

    Article • BMC Nephrology, April 2012, Springer Science + Business Media

    prof alberto ortiz

  162. Implementation of proteomic biomarkers: making it work

    Article • European Journal of Clinical Investigation, April 2012, Wiley

    Dr Frederik Persson, prof alberto ortiz

  163. Dual-Specificity Phosphatases Are Implicated in Severe Hyperplasia and Lack of Response to FGF23 of Uremic Parathyroid Glands from Rats

    Article • Endocrinology, April 2012, Endocrine Society

    prof alberto ortiz

  164. Monocyte subpopulations and cardiovascular risk in chronic kidney disease

    Article • Nature Reviews Nephrology, March 2012, Nature

    prof alberto ortiz , Prof. Carmine Zoccali

  165. GSK3, Snail, and Adhesion Molecule Regulation by Cyclosporine A in Renal Tubular Cells

    Article • Toxicological Sciences, March 2012, Oxford University Press (OUP)

    prof alberto ortiz

  166. Association between a common KCNJ11 polymorphism (rs5219) and new-onset posttransplant diabetes in patients treated with Tacrolimus

    Article • Molecular Genetics and Metabolism, March 2012, Elsevier

    prof alberto ortiz

  167. Proteome changes in the myocardium of experimental chronic diabetes and hypertension

    Article • Journal of Proteomics, March 2012, Elsevier

    prof alberto ortiz

  168. The Human Plasma Lipidome

    Article • New England Journal of Medicine, February 2012, New England Journal of Medicine (NEJM/MMS)

    prof alberto ortiz

  169. Combination therapy with an angiotensin II receptor blocker and an HMG-CoA reductase inhibitor in experimental subtotal nephrectomy

    Article • Nephrology Dialysis Transplantation, February 2012, Oxford University Press (OUP)

    prof alberto ortiz

  170. Undetectable serum calcidiol: not everything that glitters is gold

    Article • Clinical Kidney Journal, January 2012, Oxford University Press (OUP)

    prof alberto ortiz

  171. HSP27/HSPB1 as an adaptive podocyte antiapoptotic protein activated by high glucose and angiotensin II

    Article • Laboratory Investigation, January 2012, Elsevier

    Moin Saleem, prof alberto ortiz

  172. Gremlin Is a Downstream Profibrotic Mediator of Transforming Growth Factor-Beta in Cultured Renal Cells

    Article • Nephron Experimental Nephrology, January 2012, Karger Publishers

    prof alberto ortiz

  173. Risk in Dosing Regimens for 25-OH Vitamin D Supplementation in Chronic Haemodialysis Patients

    Article • Nephron Clinical Practice, January 2012, Karger Publishers

    prof alberto ortiz

  174. Antioxidants in Kidney Diseases: The Impact of Bardoxolone Methyl

    Article • International Journal of Nephrology, January 2012, Hindawi Publishing Corporation

    prof alberto ortiz

  175. Haematuria: the forgotten CKD factor?

    Article • Nephrology Dialysis Transplantation, January 2012, Oxford University Press (OUP)

    prof alberto ortiz

  176. Oxidative Stress, Macrophage Infiltration and CD163 Expression Are Determinants of Long-Term Renal Outcome in Macrohematuria-Induced Acute Kidney Injury of IgA Nephropathy

    Article • Nephron Clinical Practice, January 2012, Karger Publishers

    prof alberto ortiz

  177. Phosphorus and Nutrition in Chronic Kidney Disease

    Article • International Journal of Nephrology, January 2012, Hindawi Publishing Corporation

    prof alberto ortiz

  178. Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy

    Article • AJP Renal Physiology, December 2011, American Physiological Society

    prof alberto ortiz

  179. AKI Associated with Macroscopic Glomerular Hematuria: Clinical and Pathophysiologic Consequences

    Article • Clinical Journal of the American Society of Nephrology, November 2011, American Society of Nephrology

    Dr Luis M Blanco-Colio, prof alberto ortiz

  180. Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis

    Article • Nature Reviews Nephrology, November 2011, Nature

    prof alberto ortiz , Prof. Carmine Zoccali

  181. TWEAK, a multifunctional cytokine in kidney injury

    Article • Kidney International, October 2011, Elsevier

    prof alberto ortiz

  182. Pharmacological modulation of peritoneal injury induced by dialysis fluids: is it an option?

    Article • Nephrology Dialysis Transplantation, September 2011, Oxford University Press (OUP)

    prof alberto ortiz

  183. Delayed Graft Function and Cotrimoxazole

    Article • Transplantation Proceedings, September 2011, Elsevier

    prof alberto ortiz

  184. The Inflammatory Cytokines TWEAK and TNF  Reduce Renal Klotho Expression through NF B

    Article • Journal of the American Society of Nephrology, June 2011, American Society of Nephrology

    prof alberto ortiz

  185. Arterial aging and arterial disease: interplay between central hemodynamics, cardiac work, and organ flow—implications for CKD and cardiovascular disease

    Article • Kidney International Supplements, June 2011, Elsevier

    prof alberto ortiz , Prof. Carmine Zoccali

  186. Cardiovascular and non-cardiovascular mortality in dialysis patients: where is the link?

    Article • Kidney International Supplements, June 2011, Elsevier

    prof alberto ortiz , Prof. Carmine Zoccali

  187. Glomerulonefritis: concepto y clasificación. Etiopatogenia de las glomerulonefritis

    Article • Medicine - Programa de Formación Médica Continuada Acreditado, June 2011, Elsevier

    prof alberto ortiz

  188. Major pathways of the reno–cardiovascular link: the sympathetic and renin–angiotensin systems

    Article • Kidney International Supplements, June 2011, Elsevier

    prof alberto ortiz , Prof. Carmine Zoccali

  189. The complexity of the cardio–renal link: taxonomy, syndromes, and diseases

    Article • Kidney International Supplements, June 2011, Elsevier

    prof alberto ortiz , Prof. Carmine Zoccali

  190. The dysfunctional endothelium in CKD and in cardiovascular disease: mapping the origin(s) of cardiovascular problems in CKD and of kidney disease in cardiovascular conditions for a research agenda

    Article • Kidney International Supplements, June 2011, Elsevier

    prof alberto ortiz , Prof. Carmine Zoccali

  191. The lingering dilemma of arterial pressure in CKD: what do we know, where do we go?

    Article • Kidney International Supplements, June 2011, Elsevier

    prof alberto ortiz , Prof. Carmine Zoccali

  192. Eficacia de la suplementación oral intradiálisis en pacientes con insuficiencia renal crónica

    Article • Endocrinología y Nutrición, May 2011, Elsevier

    prof alberto ortiz

  193. Proteomics in chronic kidney disease: The issues clinical nephrologists need an answer for

    Article • PROTEOMICS - CLINICAL APPLICATIONS, April 2011, Wiley

    prof alberto ortiz

  194. Vascular proteomics and the discovery process of clinical biomarkers: The case of TWEAK

    Article • PROTEOMICS - CLINICAL APPLICATIONS, April 2011, Wiley

    prof alberto ortiz

  195. The meaning of urinary creatinine concentration

    Article • Kidney International, April 2011, Elsevier

    prof alberto ortiz

  196. Lanthanum carbonate reduces FGF23 in chronic kidney disease Stage 3 patients

    Article • Nephrology Dialysis Transplantation, March 2011, Oxford University Press (OUP)

    prof alberto ortiz

  197. Soluble TWEAK and PTX3 in Nondialysis CKD Patients: Impact on Endothelial Dysfunction and Cardiovascular Outcomes

    Article • Clinical Journal of the American Society of Nephrology, February 2011, American Society of Nephrology

    prof alberto ortiz

  198. Paricalcitol for reduction of albuminuria in diabetes

    Article • The Lancet, February 2011, Elsevier

    prof alberto ortiz

  199. Etiopathology of chronic tubular, glomerular and renovascular nephropathies: Clinical implications

    Article • Journal of Translational Medicine, January 2011, Springer Science + Business Media

    Professor Jose M Lopez-Novoa, prof alberto ortiz

  200. Animal Models of Cardiovascular Diseases

    Article • Journal of Biomedicine and Biotechnology, January 2011, Hindawi Publishing Corporation

    prof alberto ortiz

  201. Calcific uremic arteriolopathy while on cinacalcet

    Article • Journal of Postgraduate Medicine, January 2011, Medknow

    prof alberto ortiz

  202. Tenofovir Nephrotoxicity: 2011 Update

    Article • AIDS Research and Treatment, January 2011, Hindawi Publishing Corporation

    prof alberto ortiz

  203. Serum levels of matrix metalloproteinase-10 are associated with the severity of atherosclerosis in patients with chronic kidney disease

    Article • Kidney International, December 2010, Elsevier

    prof alberto ortiz , Dr Jose M Valdivielso, Jose A. Rodriguez

  204. Statins Inhibit Angiotensin II/Smad Pathway and Related Vascular Fibrosis, by a TGF-β-Independent Process

    Article • PLoS ONE, November 2010, PLOS

    prof alberto ortiz

  205. Peritonitis Due to Microbacterium sp in a Patient on Cycler Peritoneal Dialysis

    Article • Peritoneal Dialysis International, November 2010, MultiMed Inc.

    prof alberto ortiz

  206. Familial C4B deficiency and immune complex glomerulonephritis

    Article • Clinical Immunology, October 2010, Elsevier

    prof alberto ortiz

  207. New paradigms in cell death in human diabetic nephropathy

    Article • Kidney International, October 2010, Elsevier

    prof alberto ortiz

  208. Unravelling fibrosis: two newcomers and an old foe

    Article • Nephrology Dialysis Transplantation, September 2010, Oxford University Press (OUP)

    prof alberto ortiz

  209. Prognostic Indicators of Renal Disease Progression in Adults with Fabry Disease: Natural History Data from the Fabry Registry

    Article • Clinical Journal of the American Society of Nephrology, September 2010, American Society of Nephrology

    prof alberto ortiz , Dr Bojan Vujkovac

  210. Glomerular haematuria, renal interstitial haemorrhage and acute kidney injury

    Article • Nephrology Dialysis Transplantation, August 2010, Oxford University Press (OUP)

    prof alberto ortiz

  211. NF- B in Renal Inflammation

    Article • Journal of the American Society of Nephrology, July 2010, American Society of Nephrology

    prof alberto ortiz

  212. Functional polymorphisms in the CYP3A4, CYP3A5, and CYP21A2 genes in the risk for hypertension in pregnancy

    Article • Biochemical and Biophysical Research Communications, July 2010, Elsevier

    prof alberto ortiz

  213. 'Reality and desire' in the care of advanced chronic kidney disease

    Article • Clinical Kidney Journal, June 2010, Oxford University Press (OUP)

    prof alberto ortiz

  214. PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage

    Article • Laboratory Investigation, June 2010, Nature

    prof alberto ortiz

  215. The expanding spectrum of biological actions of vitamin D

    Article • Nephrology Dialysis Transplantation, June 2010, Oxford University Press (OUP)

    prof alberto ortiz

  216. Globotriaosylsphingosine actions on human glomerular podocytes: implications for Fabry nephropathy

    Article • Nephrology Dialysis Transplantation, May 2010, Oxford University Press (OUP)

    prof alberto ortiz

  217. UGA hopping: a sport for nephrologists too?

    Article • Nephrology Dialysis Transplantation, May 2010, Oxford University Press (OUP)

    prof alberto ortiz

  218. Caspase-12 and Diabetic Nephropathy: From Mice to Men?

    Article • Journal of the American Society of Nephrology, May 2010, American Society of Nephrology

    prof alberto ortiz

  219. Tyrphostins as Potential Therapeutic Agents for Acute Kidney Injury

    Article • Current Medicinal Chemistry, April 2010, Bentham Science Publishers

    prof alberto ortiz

  220. Local Non-Esterified Fatty Acids Correlate With Inflammation in Atheroma Plaques of Patients With Type 2 Diabetes

    Article • Diabetes, March 2010, American Diabetes Association

    prof alberto ortiz

  221. Suppressors of Cytokine Signaling Abrogate Diabetic Nephropathy

    Article • Journal of the American Society of Nephrology, February 2010, American Society of Nephrology

    prof alberto ortiz

  222. TWEAK Activates the Non-Canonical NFκB Pathway in Murine Renal Tubular Cells: Modulation of CCL21

    Article • PLoS ONE, January 2010, PLOS

    prof alberto ortiz

  223. BASP1 Promotes Apoptosis in Diabetic Nephropathy

    Article • Journal of the American Society of Nephrology, January 2010, American Society of Nephrology

    prof alberto ortiz

  224. BMP-7 blocks mesenchymal conversion of mesothelial cells and prevents peritoneal damage induced by dialysis fluid exposure

    Article • Nephrology Dialysis Transplantation, January 2010, Oxford University Press (OUP)

    prof alberto ortiz

  225. Regulation of Vascular and Renal Cells by Common Mediators in Health and Disease: Role of the Renin—Angiotensin System in the Pathophysiology of Hypertension and Cardiovascular Disease

    Article • January 2010, Springer Science + Business Media

    prof alberto ortiz

  226. TNF Superfamily: A Growing Saga of Kidney Injury Modulators

    Article • Mediators of Inflammation, January 2010, Hindawi Publishing Corporation

    prof alberto ortiz

  227. Nephrin mutations cause childhood- and adult-onset focal segmental glomerulosclerosis

    Article • Kidney International, December 2009, Elsevier

    prof alberto ortiz , MD, PhD Guillem PINTOS-MORELL

  228. Detection of lfrA and tap efflux pump genes among clinical isolates of non-pigmented rapidly growing mycobacteria

    Article • International Journal of Antimicrobial Agents, November 2009, Elsevier

    prof alberto ortiz

  229. End-stage renal disease in patients with Fabry disease: natural history data from the Fabry Registry

    Article • Nephrology Dialysis Transplantation, October 2009, Oxford University Press (OUP)

    prof alberto ortiz , Dr Bojan Vujkovac

  230. Myocardial fibrosis and apoptosis, but not inflammation, are present in long-term experimental diabetes

    Article • AJP Heart and Circulatory Physiology, October 2009, American Physiological Society

    prof alberto ortiz

  231. Soluble TWEAK Plasma Levels as a Novel Biomarker of Endothelial Function in Patients with Chronic Kidney Disease

    Article • Clinical Journal of the American Society of Nephrology, October 2009, American Society of Nephrology

    prof alberto ortiz

  232. Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK) Enhances Vascular and Renal Damage Induced by Hyperlipidemic Diet in ApoE-Knockout Mice

    Article • Arteriosclerosis Thrombosis and Vascular Biology, September 2009, Wolters Kluwer Health

    prof alberto ortiz

  233. Estrategias en la profilaxis y el tratamiento de la malnutrición en diálisis peritoneal: un problema infradiagnosticado

    Article • Diálisis y Trasplante, September 2009, Elsevier

    prof alberto ortiz

  234. A Nanoconjugate Apaf-1 Inhibitor Protects Mesothelial Cells from Cytokine-Induced Injury

    Article • PLoS ONE, August 2009, PLOS

    Jaime Esteban, prof alberto ortiz

  235. 2nd Combined Working Group and Management Committee Meeting of Urine and Kidney Proteomics COST Action 29-30 March 2009, Nafplio, Greece

    Article • PROTEOMICS - CLINICAL APPLICATIONS, August 2009, Wiley

    prof alberto ortiz , Dr Vasilis J Promponas, Gian Marco Ghiggeri

  236. Inhibition of p38-MAPK Potentiates Cisplatin-Induced Apoptosis via GSH Depletion and Increases Intracellular Drug Accumulation in Growth-Arrested Kidney Tubular Epithelial Cells

    Article • Toxicological Sciences, July 2009, Oxford University Press (OUP)

    prof alberto ortiz

  237. Considering TWEAK as a target for therapy in renal and vascular injury

    Article • Cytokine & Growth Factor Reviews, June 2009, Elsevier

    prof alberto ortiz

  238. Patogénesis de la malnutrición en pacientes en diálisis con énfasis en los aspectos más específicos de la diálisis peritoneal

    Article • Diálisis y Trasplante, June 2009, Elsevier

    prof alberto ortiz

  239. TRPC6 mutational analysis in a large cohort of patients with focal segmental glomerulosclerosis

    Article • Nephrology Dialysis Transplantation, May 2009, Oxford University Press (OUP)

    prof alberto ortiz , MD, PhD Guillem PINTOS-MORELL

  240. Increased CD74 expression in human atherosclerotic plaques: contribution to inflammatory responses in vascular cells

    Article • Cardiovascular Research, May 2009, European Society of Cardiology

    prof alberto ortiz

  241. CTGF Promotes Inflammatory Cell Infiltration of the Renal Interstitium by Activating NF- B

    Article • Journal of the American Society of Nephrology, May 2009, American Society of Nephrology

    prof alberto ortiz

  242. Tweak induces proliferation in renal tubular epithelium: a role in uninephrectomy induced renal hyperplasia

    Article • Journal of Cellular and Molecular Medicine, May 2009, Wiley

    prof alberto ortiz

  243. Nephropathy in Fabry disease: the importance of early diagnosis and testing in high-risk populations

    Article • Nephrology Dialysis Transplantation, March 2009, Oxford University Press (OUP)

    prof alberto ortiz

  244. Additive Effects of Soluble TWEAK and Inflammation on Mortality in Hemodialysis Patients

    Article • Clinical Journal of the American Society of Nephrology, January 2009, American Society of Nephrology

    prof alberto ortiz

  245. Inhibition of JAK2 protects renal endothelial and epithelial cells from oxidative stress and cyclosporin A toxicity

    Article • Kidney International, January 2009, Elsevier

    prof alberto ortiz

  246. Essential Role of TGF-β/Smad Pathway on Statin Dependent Vascular Smooth Muscle Cell Regulation

    Article • PLoS ONE, December 2008, PLOS

    prof alberto ortiz

  247. Hyperphosphatemia and hyperparathyroidism in incident chronic kidney disease patients

    Article • Kidney International, December 2008, Elsevier

    prof alberto ortiz

  248. Gliotoxin Inhibits Neointimal Hyperplasia after Vascular Injury in Rats

    Article • Journal of Vascular Research, November 2008, Karger Publishers

    prof alberto ortiz

  249. Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation

    Article • Kidney International, September 2008, Elsevier

    prof alberto ortiz

  250. Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis

    Article • Nephrology Dialysis Transplantation, August 2008, Oxford University Press (OUP)

    prof alberto ortiz

  251. Mechanisms of Renal Apoptosis in Health and Disease

    Article • Journal of the American Society of Nephrology, August 2008, American Society of Nephrology

    prof alberto ortiz

  252. A search for cyclophilin-A gene variants in cyclosporine A-treated renal transplanted patients

    Article • Clinical Transplantation, July 2008, Wiley

    prof alberto ortiz

  253. ACE gene polymorphism and the prognosis and treatment of overt diabetic nephropathy

    Article • Nature Clinical Practice Nephrology, July 2008, Nature

    prof alberto ortiz

  254. Pharmacological Modulation of Epithelial Mesenchymal Transition Caused by Angiotensin II. Role of ROCK and MAPK Pathways

    Article • Pharmaceutical Research, July 2008, Springer Science + Business Media

    prof alberto ortiz

  255. A Slit in Podocyte Death

    Article • Current Medicinal Chemistry, July 2008, Bentham Science Publishers

    prof alberto ortiz

  256. 3,4-Dideoxyglucosone-3-ene as a mediator of peritoneal demesothelization

    Article • Nephrology Dialysis Transplantation, June 2008, Oxford University Press (OUP)

    prof alberto ortiz

  257. Severe everolimus-associated pneumonitis in a renal transplant recipient

    Article • Nephrology Dialysis Transplantation, June 2008, Oxford University Press (OUP)

    prof alberto ortiz

  258. Recommendations and guidelines for the diagnosis and treatment of Fabry nephropathy in adults

    Article • Nature Clinical Practice Nephrology, April 2008, Nature

    prof alberto ortiz

  259. Benefits of preserving residual renal function in peritoneal dialysis

    Article • Kidney International, April 2008, Elsevier

    prof alberto ortiz

  260. The Cytokine TWEAK Modulates Renal Tubulointerstitial Inflammation

    Article • Journal of the American Society of Nephrology, March 2008, American Society of Nephrology

    prof alberto ortiz

  261. Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy

    Article • Nephrology Dialysis Transplantation, February 2008, Oxford University Press (OUP)

    prof alberto ortiz

  262. The Death Ligand TRAIL in Diabetic Nephropathy

    Article • Journal of the American Society of Nephrology, February 2008, American Society of Nephrology

    prof alberto ortiz

  263. Females with Fabry disease frequently have major organ involvement: Lessons from the Fabry Registry

    Article • Molecular Genetics and Metabolism, February 2008, Elsevier

    Professor Ulla Feldt-Rasmussen, prof alberto ortiz

  264. TWEAKing renal injury

    Article • Frontiers in Bioscience, January 2008, Frontiers in Bioscience

    prof alberto ortiz

  265. Renal cell apoptosis induced by nephrotoxic drugs: cellular and molecular mechanisms and potential approaches to modulation

    Article • APOPTOSIS, October 2007, Springer Science + Business Media

    prof alberto ortiz

  266. Emphysematous Pyelonephritis in Dialysis Patient After Embolization of Failed Allograft

    Article • Urology, August 2007, Elsevier

    prof alberto ortiz

  267. Identification of Soluble Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (sTWEAK) as a Possible Biomarker of Subclinical Atherosclerosis

    Article • Arteriosclerosis Thrombosis and Vascular Biology, April 2007, Wolters Kluwer Health

    prof alberto ortiz

  268. Endovascular repair of mycotic aneurysms of the aorta: An alternative to conventional bypass surgery in patients with acute sepsis

    Article • Scandinavian Journal of Infectious Diseases, January 2007, Taylor & Francis

    prof alberto ortiz

  269. TWEAK and Fn14. New players in the pathogenesis of atherosclerosis

    Article • Frontiers in Bioscience, January 2007, Frontiers in Bioscience

    prof alberto ortiz

  270. Cytokine cooperation in renal tubular cell injury: The role of TWEAK

    Article • Kidney International, November 2006, Elsevier

    prof alberto ortiz

  271. 3,4-DGE is Important for Side Effects in Peritoneal Dialysis What About its Role in Diabetes

    Article • Current Medicinal Chemistry, September 2006, Bentham Science Publishers

    prof alberto ortiz

  272. Impact of end-stage renal disease care in planned dialysis start and type of renal replacement therapy--a Spanish multicentre experience

    Article • Nephrology Dialysis Transplantation, July 2006, Oxford University Press (OUP)

    prof alberto ortiz

  273. Peritoneal defence--lessons learned which apply to diabetes complications

    Article • Nephrology Dialysis Transplantation, July 2006, Oxford University Press (OUP)

    prof alberto ortiz

  274. Fn14 Is Upregulated in Cytokine-Stimulated Vascular Smooth Muscle Cells and Is Expressed in Human Carotid Atherosclerotic Plaques: Modulation by Atorvastatin

    Article • Stroke, June 2006, Wolters Kluwer Health

    prof alberto ortiz

  275. Lethal activity of FADD death domain in renal tubular epithelial cells

    Article • Kidney International, June 2006, Elsevier

    prof alberto ortiz

  276. 3,4-di-deoxyglucosone-3-ene promotes leukocyte apoptosis

    Article • Kidney International, September 2005, Elsevier

    prof alberto ortiz

  277. Angiotensin II and Reactive Oxygen Species

    Article • Antioxidants & Redox Signaling, September 2005, Mary Ann Liebert Inc

    prof alberto ortiz

  278. Long-Term Blood Pressure Control Prevents Oxidative Renal Injury

    Article • Antioxidants & Redox Signaling, September 2005, Mary Ann Liebert Inc

    prof alberto ortiz

  279. 3,4-Dideoxyglucosone-3-ene Induces Apoptosis in Renal Tubular Epithelial Cells

    Article • Diabetes, July 2005, American Diabetes Association

    prof alberto ortiz

  280. Soporte nutricional en la insuficiencia renal crónica

    Article • Endocrinología y Nutrición, May 2005, Elsevier

    prof alberto ortiz

  281. Role of Bcl-xL in paracetamol-induced tubular epithelial cell death

    Article • Kidney International, February 2005, Elsevier

    prof alberto ortiz

  282. Modulation of survival in osteoblasts from postmenopausal women

    Article • Bone, July 2004, Elsevier

    prof alberto ortiz

  283. Tight blood pressure control decreases apoptosis during renal damage

    Article • Kidney International, March 2004, Elsevier

    prof alberto ortiz

  284. Paracetamol-Induced Renal Tubular Injury: A Role for ER Stress

    Article • Journal of the American Society of Nephrology, February 2004, American Society of Nephrology

    prof alberto ortiz

  285. Intracellular Mechanisms of Cyclosporin A-Induced Tubular Cell Apoptosis

    Article • Journal of the American Society of Nephrology, December 2003, American Society of Nephrology

    prof alberto ortiz

  286. Targeting apoptosis in acute tubular injury

    Article • Biochemical Pharmacology, October 2003, Elsevier

    prof alberto ortiz

  287. Bcl-xL overexpression protects from apoptosis induced by HMG-CoA reductase inhibitors in murine tubular cells

    Article • Kidney International, July 2003, Elsevier

    prof alberto ortiz , PhD Ilse Daehn Daehn

  288. Regulation of apoptosis by lethal cytokines in human mesothelial cells

    Article • Kidney International, July 2003, Elsevier

    prof alberto ortiz

  289. Staining for cell death

    Article • The Lancet, May 2003, Elsevier

    prof alberto ortiz

  290. Role of Endogenous Vascular Endothelial Growth Factor in Tubular Cell Protection Against Acute Cyclosporine Toxicity1

    Article • Transplantation, December 2002, Wolters Kluwer Health

    prof alberto ortiz

  291. Pseudomonas oryzihabitans peritonitis in a patient on continuous ambulatory peritoneal dialysis

    Article • Clinical Microbiology and Infection, September 2002, Elsevier

    prof alberto ortiz

  292. Renal cell loss through cell suicide

    Article • Kidney International, November 2000, Elsevier

    prof alberto ortiz

  293. Expression of apoptosis regulatory proteins in tubular epithelium stressed in culture or following acute renal failure

    Article • Kidney International, March 2000, Elsevier

    prof alberto ortiz

  294. The Fas ligand/Fas system in renal injury

    Article • Nephrology Dialysis Transplantation, August 1999, Oxford University Press (OUP)

    prof alberto ortiz

  295. Role of cytokines in the response to erythropoietin in hemodialysis patients

    Article • Kidney International, October 1998, Elsevier

    prof alberto ortiz

  296. Hepatitis B Virus Infection

    Article • New England Journal of Medicine, April 1998, New England Journal of Medicine (NEJM/MMS)

    prof alberto ortiz

  297. Circulating Endothelial Cells in Sickle Cell Anemia

    Article • New England Journal of Medicine, April 1998, New England Journal of Medicine (NEJM/MMS)

    prof alberto ortiz

  298. Epithelial differentiation of metanephric mesenchymal cells after stimulation with hepatocyte growth factor or embryonic spinal cord.

    Article • Proceedings of the National Academy of Sciences, June 1994, Proceedings of the National Academy of Sciences

    prof alberto ortiz

  299. Cefazolin-Induced Neurotoxicity

    Article • Clinical Infectious Diseases, February 1992, Oxford University Press (OUP)

    prof alberto ortiz

  300. Effect of Recombinant Human Growth Hormone in a Postpediatric Hemodialysis Patient with Delayed Growth

    Article • American Journal of Nephrology, January 1992, Karger Publishers

    prof alberto ortiz

  301. Presence of circulating antibodies against brush border antigens (FxlA) in a patient with membranous nephropathy and bilateral pyeloureteral stenosis. Comparison with idiopathic membranous nephropathy

    Article • Nephrology Dialysis Transplantation, January 1992, Oxford University Press (OUP)

    prof alberto ortiz

  302. Salmonella enteritidis empyema complicating lupus pleuritis.

    Article • Postgraduate Medical Journal, August 1991, BMJ

    prof alberto ortiz

  303. Involvement of Lipid Mediators in the Pathogenesis of Experimental Nephrosis in Rats: Its Pharmacological Modulation

    Article • Renal Failure, January 1991, Taylor & Francis

    prof alberto ortiz

  304. Role of platelet-activating factor in adriamycin-induced nephropathy in rats

    Article • European Journal of Pharmacology, June 1987, Elsevier

    prof alberto ortiz

  305. Apoptosis in the Kidney

    Article • Cambridge University Press

    prof alberto ortiz

  306. Nephrotoxicity

    Article • Wiley

    prof alberto ortiz , Dr Alberto Ortiz-Vigón